CHEMOS
LP-01

LP-01

Nom chimique

[2-[3-(diethylamino)propoxycarbonyloxymethyl]-3-(4,4-dioctoxybutanoyloxy)propyl] (9Z,12Z)-octadeca-9,12-dienoate

LP-01•LNP
Structure: LP-01 structure, CAS 1799316-64-5, MW 852.27
N° produit
CH51068
CAS
1799316-64-5
FM
C50H93NO9
PM
852.27
Spécification
Catalog No.CH51068
CAS No.1799316-64-5
Molecular FormulaC50H93NO9
Molecular Weight852.27

CHEMOS Support for This Category

CHEMOS supports custom synthesis and process development for LNP lipid components, with work planned according to target structure, requested scale, and analytical requirements. Ionizable lipid route development : route scouting, impurity review, stereochemistry control, and purification planning. Helper lipid and PEG-lipid preparation : support for phospholipids, sterol-related components, PEG-lipids, and related analogs. Analytical support : HPLC, NMR, MS, Karl Fischer water content, elemental analysis, and residual-solvent testing can be discussed by project. Scale-up support : transfer from laboratory preparation to larger pilot or production batches after route and quality review. Project documentation : batch-specific COA and technical information are provided according to the confirmed specification.

Vue d’ensemble

LP-01 (also known as [2-[3-(diethylamino)propoxycarbonyloxymethyl]-3-(4,4-dioctoxybutanoyloxy)propyl] (9Z,12Z)-octadeca-9,12-dienoate) (CAS 1799316-64-5, MF C50H93NO9, MW 852.27) is a lipid-like delivery-system component studied in formulation research. Practical chemistry questions usually involve identity, regio-chemistry, and related-species impurities. Project scale-up and custom synthesis are coordinated by the CHEMOS R&D team across laboratory and production sites.

Applications

  • LP-01 (CAS 1799316-64-5) preparation, route refinement, and analytical-control planning
  • Reference material for delivery-system composition studies
  • Custom synthesis and analog preparation for delivery research

Besoin d’une synthèse à façon ?

Notre équipe CDMO accompagne la synthèse à façon, de l’évaluation de voie au développement de procédé et au scale-up.

Voir les services CDMO